Usana Health Sciences R&D Spending Growth & History (USNA)

Usana Health Sciences's r&d spending was $10.7M for fiscal 2025.

View full Usana Health Sciences company overview

Usana Health Sciences annual r&d spending history

Usana Health Sciences annual r&d spending

Fiscal yearPeriod endedR&D spendingChangeGrowth
20252026-01-03$10.7M−$878,000−7.59%
20242024-12-28$11.6M$125,000+1.09%
20232023-12-30$11.4M−$117,000−1.01%
20222022-12-31$11.6M$451,000+4.06%
20212022-01-01$11.1M$479,000+4.50%
20202021-01-02$10.6M$374,000+3.65%
20192019-12-28$10.3M$17,000+0.17%
20182018-12-29$10.2M$1.3M+14.41%
20172017-12-30$9.0M$110,000+1.24%
20162016-12-31$8.8M$2.4M+37.73%
20152016-01-02$6.4M$1.3M+25.20%
20142015-01-03$5.1M$45,000+0.89%
20132013-12-28$5.1M$419,000+8.98%
20122012-12-29$4.7M$593,000+14.57%
20112011-12-31$4.1M$229,000+5.96%
20102011-01-01$3.8M

Usana Health Sciences r&d spending trends

Over the last five fiscal years, Usana Health Sciences's r&d spending increased from $10.6M to $10.7M, a change of $60,000.

About the metric

What research and development spending means

Research and development (R&D) spending covers the costs of creating and improving products, services, software, technologies, and processes. Higher R&D spending may support future innovation, but the amount alone does not show whether those investments will generate returns.

Calculation and source

SEC-reported R&D expense

TickerStat standardizes research and development expense reported in company SEC filings, including the software-specific US-GAAP R&D concept when it is the filer’s primary R&D expense line. It is historical company-reported spending, not an estimate or forecast. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Usana Health Sciences source filings ↗

Community posts

It’s quiet here.

No posts about USNA yet. Start the conversation.

Write the first post